AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31798895 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing to improve adherence to healthy eating in addition to routine care
Number of subjects: 189
Study 31798895 — intervention group
Group type: COMPARATOR
Intervention: Routine care only (reference cohort)
Number of subjects: 189
Study 30200800 — intervention group
Group type: EXPERIMENTAL
Intervention: YAG laser vitreolysis
Number of subjects: 30
Study 27483995 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital outreach rehabilitation program
Number of subjects: 28
Study 27483995 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 28
Study 24332259 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise program (6 weeks duration)
Number of subjects: 20
Study 22730816 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized budesonide suspension (1 mg twice daily) via transnasal inhalation for one week
Number of subjects: 30
Study 22730816 — intervention group
Group type: COMPARATOR
Intervention: Budesonide nasal spray (256 microg twice daily)
Number of subjects: 30
Study 22730816 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized budesonide
Number of subjects: 30
Study 20932512 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent Training (PT) intervention
Number of subjects: 0
Study 20932512 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 0
Study 18470602 — intervention group
Group type: EXPERIMENTAL
Intervention: Right ventricular apex (RVA)
Number of subjects: 26
Study 18470602 — intervention group
Group type: COMPARATOR
Intervention: Right ventricular outflow tract (RVOT)
Number of subjects: 26
Study 15847949 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamycin (GM) eardrops
Number of subjects: 95
Study 15847949 — intervention group
Group type: COMPARATOR
Intervention: Gentamycin-steroid combination (GM-S) eardrops
Number of subjects: 95
Study 12563493 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ)
Number of subjects: 0
Study 12563493 — intervention group
Group type: COMPARATOR
Intervention: Sulfadoxine/pyrimethamine (SP)
Number of subjects: 0
Study 10326918 — intervention group
Group type: EXPERIMENTAL
Intervention: Semirigid orthotics
Number of subjects: 12
Study 10326918 — intervention group
Group type: COMPARATOR
Intervention: Nonorthotic condition
Number of subjects: 12
Study 7841356 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation (ferrous sulphate drops: 3 mg/Kg/day)
Number of subjects: 36
Study 7841356 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal subjects)
Number of subjects: 36
Study 7841356 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron deficiency without anemia (ID)
Number of subjects: 36
Study 3411737 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum plus group (trained physicians)
Number of subjects: 70
Study 3411737 — intervention group
Group type: COMPARATOR
Intervention: Gum only group (physicians offered nicotine gum)
Number of subjects: 70
Study 3411737 — intervention group
Group type: COMPARATOR
Intervention: Usual care group (standard care)
Number of subjects: 70
Study 29921730 — intervention group
Group type: EXPERIMENTAL
Intervention: CIMP+ patients
Number of subjects: 1907
Study 29921730 — intervention group
Group type: COMPARATOR
Intervention: Cetuximab in CIMP+ tumors
Number of subjects: 1907
Study 28679643 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional GM‐CSF (500 mcg standard dose)
Number of subjects: 9
Study 28679643 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA) + GM‐CSF
Number of subjects: 9
Study 28679643 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoablation + GM‐CSF
Number of subjects: 9
Study 28679643 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival (OS)
Number of subjects: 9
Study 28679643 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction of endogenous HSP70 and melanoma-specific cytotoxic T lymphocytes (CTL)
Number of subjects: 9
Study 23852313 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Theta Burst Stimulation (cTBS)
Number of subjects: 55
Study 23852313 — intervention group
Group type: COMPARATOR
Intervention: High-frequency rTMS (10 Hz)
Number of subjects: 55
Study 22751755 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist‐assisted medication reconciliation, inpatient pharmacist counseling, low‐literacy adherence aids, and individualized telephone follow‐up after discharge
Number of subjects: 851
Study 20356582 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous cycle (n=10)
Number of subjects: 64
Study 20356582 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovulation induction with clomiphene‐citrate (n=15)
Number of subjects: 64
Study 20356582 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovulation induction with gonadotropins (n=9)
Number of subjects: 64
Study 20356582 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled ovarian hyperstimulation for IVF (COH‐IVF; n=10)
Number of subjects: 64
Study 20356582 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenous E2 for frozen‐thawed embryo‐transfer (FET; n=20)
Number of subjects: 64
Study 18197095 — intervention group
Group type: EXPERIMENTAL
Intervention: FlexiCore
Number of subjects: 67
Study 18197095 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 67
Study 16685822 — intervention group
Group type: EXPERIMENTAL
Intervention: SVM classification using the best set of features
Number of subjects: 61
Study 12907530 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific expiratory muscle training (SEMT), daily, six times a week, 1/2 hour per session for 3 months
Number of subjects: 26
Study 12907530 — intervention group
Group type: COMPARATOR
Intervention: Control group (very low load training)
Number of subjects: 26
Study 10472466 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-buffered saline solution
Number of subjects: 30
Study 10472466 — intervention group
Group type: EXPERIMENTAL
Intervention: Buffered saline solution (pH 8)
Number of subjects: 30
Study 10472466 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 30
Study 8979657 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication alarm device (TimeCap)
Number of subjects: 13
Study 8979657 — intervention group
Group type: COMPARATOR
Intervention: No medication alarm device (Control)
Number of subjects: 13
Study 1612814 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine (0.4 mg)
Number of subjects: 0
Study 1612814 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular morphine (10 mg)
Number of subjects: 0
Study 6378733 — intervention group
Group type: EXPERIMENTAL
Intervention: Antacids and/or anticholinergic drugs
Number of subjects: 75
Study 31852902 — intervention group
Group type: EXPERIMENTAL
Intervention: Foster care intervention
Number of subjects: 0
Study 31852902 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 0
Study 31852902 — intervention group
Group type: COMPARATOR
Intervention: Never-institutionalized children
Number of subjects: 0
Study 29573330 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinzaparin 175 IU kg-1 once daily
Number of subjects: 900
Study 29573330 — intervention group
Group type: COMPARATOR
Intervention: Warfarin (target INR of 2.0-3.0)
Number of subjects: 900
Study 26433207 — intervention group
Group type: EXPERIMENTAL
Intervention: Alanine aminotransferase levels
Number of subjects: 0
Study 26433207 — intervention group
Group type: EXPERIMENTAL
Intervention: Alanine aminotransferase levels below reference range
Number of subjects: 0
Study 26433207 — intervention group
Group type: EXPERIMENTAL
Intervention: Alanine aminotransferase levels above reference range
Number of subjects: 0
Study 26433207 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma‐glutamyltransferase levels
Number of subjects: 0
Study 24192009 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse support
Number of subjects: 461
Study 24192009 — intervention group
Group type: COMPARATOR
Intervention: Education
Number of subjects: 461
Study 24192009 — intervention group
Group type: COMPARATOR
Intervention: Enhanced care
Number of subjects: 461
Study 22863206 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong training (level 1 Chaoyi Fanhuan Qigong, CFQ), given over three half‐days, followed by weekly review/practice sessions for eight weeks, with home practice for 45 to 60 minutes per day.
Number of subjects: 100
Study 22863206 — intervention group
Group type: COMPARATOR
Intervention: Wait-list/usual care control group
Number of subjects: 100
Study 21058479 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy group of Four Points of Throat acupuncture and routine medication (group 1)
Number of subjects: 60
Study 21058479 — intervention group
Group type: COMPARATOR
Intervention: Routine medication only (group 2)
Number of subjects: 60
Study 18198327 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based health promotion intervention including six nutrition units and 20-minute running games in the first year.
Number of subjects: 1764
Study 15861018 — intervention group
Group type: EXPERIMENTAL
Intervention: omeprazole + amoxicillin with metronidazole
Number of subjects: 265
Study 15861018 — intervention group
Group type: COMPARATOR
Intervention: omeprazole + amoxicillin with clarithromycin
Number of subjects: 265
Study 15861018 — intervention group
Group type: EXPERIMENTAL
Intervention: omeprazole + amoxicillin with metronidazole (metronidazole-susceptible bacteria)
Number of subjects: 265
Study 15861018 — intervention group
Group type: EXPERIMENTAL
Intervention: omeprazole + amoxicillin with metronidazole (metronidazole-resistant bacteria)
Number of subjects: 265
Study 15861018 — intervention group
Group type: COMPARATOR
Intervention: omeprazole + amoxicillin with clarithromycin (clarithromycin-sensitive strains)
Number of subjects: 265
Study 15861018 — intervention group
Group type: COMPARATOR
Intervention: omeprazole + amoxicillin with clarithromycin (clarithromycin-resistant strains)
Number of subjects: 265
Study 11967720 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo + Ang II infusion (A)
Number of subjects: 9
Study 11967720 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan + Ang II infusion (VA)
Number of subjects: 9
Study 11967720 — intervention group
Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 9
Study 9464723 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal PGE2 gel (2 mg)
Number of subjects: 247
Study 9464723 — intervention group
Group type: COMPARATOR
Intervention: Intracervical PGE2 gel (0.5 mg)
Number of subjects: 247
Study 7796228 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin administration for prophylaxis
Number of subjects: 5245
Study 7796228 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin administration for treatment
Number of subjects: 5245
Study 2024814 — intervention group
Group type: EXPERIMENTAL
Intervention: Plugged telescoping catheter (PTC)
Number of subjects: 55
Study 2024814 — intervention group
Group type: COMPARATOR
Intervention: Protected specimen brush (PSB)
Number of subjects: 55
Study 7008655 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 1 or 2 mg
Number of subjects: 20
Study 7008655 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 2 mg
Number of subjects: 20
Study 7008655 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 2% (local perineal infiltration)
Number of subjects: 20
Study 7008655 — intervention group
Group type: EXPERIMENTAL
Intervention: Pudendal block
Number of subjects: 20
Study 7008655 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural block
Number of subjects: 20
Study 7008655 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine
Number of subjects: 20
Study 7008655 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 20
Study 31792878 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine drops with ethanol (red morphine drops, RMD)
Number of subjects: 0
Study 31792878 — intervention group
Group type: COMPARATOR
Intervention: Morphine drops without ethanol
Number of subjects: 0
Study 30366577 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (400 IU/d)
Number of subjects: 0
Study 30366577 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30366577 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct UV light exposure
Number of subjects: 0
Study 28091446 — intervention group
Group type: EXPERIMENTAL
Intervention: One-hour running (Group B)
Number of subjects: 3600
Study 28091446 — intervention group
Group type: EXPERIMENTAL
Intervention: 90-minute running (Group C)
Number of subjects: 3600
Study 28091446 — intervention group
Group type: COMPARATOR
Intervention: Half-hour running (Group A)
Number of subjects: 3600
Study 26106113 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous recombinant tissue-type plasminogen activator (IV r‐tPA)
Number of subjects: 106
Study 26106113 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 106
Study 23266331 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching exercise program (SEP)
Number of subjects: 127
Study 23266331 — intervention group
Group type: COMPARATOR
Intervention: Usual activities
Number of subjects: 127
Study 22306962 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity aerobic exercise for 30 min
Number of subjects: 40
Study 22306962 — intervention group
Group type: COMPARATOR
Intervention: Control group (watched a running/exercise-related video)
Number of subjects: 40
Study 21129341 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring system (CGMS) with low glucose alarm set at 80 mg/dl for 3 days
Number of subjects: 14
Study 21129341 — intervention group
Group type: COMPARATOR
Intervention: No alarm condition
Number of subjects: 14
Study 17418727 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma interleukin‐6 (IL‐6)
Number of subjects: 11
Study 17418727 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma interleukin‐10 (IL‐10)
Number of subjects: 11
Study 17418727 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional escape rate (FER) of Evans blue
Number of subjects: 11
Study 17418727 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloid osmotic pressure (COP)
Number of subjects: 11
Study 15883637 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate (5 mg daily for 2 years, then 10 mg for 1-2.5 years)
Number of subjects: 3658
Study 15603033 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 microg misoprostol vaginal gel
Number of subjects: 238
Study 15603033 — intervention group
Group type: COMPARATOR
Intervention: 5 mg of prostaglandin E2 gel
Number of subjects: 238
Study 9481721 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intravenous intradialysis rHuEpo therapy
Number of subjects: 20
Study 9481721 — intervention group
Group type: COMPARATOR
Intervention: Intravenous postdialysis rHuEpo therapy (control)
Number of subjects: 20
Study 7616279 — intervention group
Group type: EXPERIMENTAL
Intervention: Unicortical Caspar cervical plating screw
Number of subjects: 99
Study 7616279 — intervention group
Group type: COMPARATOR
Intervention: Bicortical Caspar cervical plating screw
Number of subjects: 99
Study 2575796 — intervention group
Group type: EXPERIMENTAL
Intervention: Pipothiazine palmitate
Number of subjects: 0
Study 2575796 — intervention group
Group type: COMPARATOR
Intervention: Fluphenazine decanoate
Number of subjects: 0
Study 791537 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment (one or more aortocoronary saphenous vein bypass grafts)
Number of subjects: 113
Study 791537 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment (conventional medical treatment)
Number of subjects: 113
Study 791537 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 113
Study 791537 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 113
Study 31880975 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined oncologist-patient/caregiver intervention
Number of subjects: 60
Study 31880975 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study 31407549 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/kg TXA administered intravenously before 5-10 minutes of operation (Group A)
Number of subjects: 72
Study 31407549 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/kg TXA administered intravenously before 5-10 minutes of operation (Group B)
Number of subjects: 72
Study 28697050 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy (hemoglobin 7-8 g/dL)
Number of subjects: 345
Study 28697050 — intervention group
Group type: COMPARATOR
Intervention: Liberal transfusion strategy (hemoglobin 10-11 g/dL)
Number of subjects: 345
Study 26673788 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative chemotherapy with bevacizumab (BEV) in combination with cytoreductive surgery (CRS) and oxaliplatin-based intraperitoneal chemoperfusion (IPC)
Number of subjects: 0
Study 26673788 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative chemotherapy with bevacizumab (BEV)
Number of subjects: 0
Study 23531438 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5mg oral tibolone (n=11)
Number of subjects: 24
Study 23531438 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.25mg oral tibolone (n=13)
Number of subjects: 24
Study 22065593 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy
Number of subjects: 70
Study 22065593 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 70
Study 19735620 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 3580
Study 19735620 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 3580
Study 17719314 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/day
Number of subjects: 9001
Study 17719314 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day
Number of subjects: 9001
Study 17719314 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin (both dosages)
Number of subjects: 9001
Study 15048740 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-assisted RYGBP
Number of subjects: 50
Study 15048740 — intervention group
Group type: COMPARATOR
Intervention: Open RYGBP
Number of subjects: 50
Study 11356774 — intervention group
Group type: COMPARATOR
Intervention: multimodal exercise intervention
Number of subjects: 67
Study 9040295 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin
Number of subjects: 432
Study 9040295 — intervention group
Group type: COMPARATOR
Intervention: Intravenous heparin
Number of subjects: 432
Study 8250306 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil 10 micrograms plus epinephrine 200 micrograms
Number of subjects: 41
Study 8250306 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil 10 micrograms plus morphine 250 micrograms
Number of subjects: 41
Study 8250306 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil 10 micrograms
Number of subjects: 41
Study 3114189 — intervention group
Group type: EXPERIMENTAL
Intervention: Pion therapy
Number of subjects: 228
Study 30106868 — intervention group
Group type: EXPERIMENTAL
Intervention: LifeFlow
Number of subjects: 54
Study 30106868 — intervention group
Group type: COMPARATOR
Intervention: Pressure bag
Number of subjects: 54
Study 30106868 — intervention group
Group type: COMPARATOR
Intervention: Push/pull
Number of subjects: 54
Study 28424025 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective reminding condition (SR)
Number of subjects: 21
Study 28424025 — intervention group
Group type: COMPARATOR
Intervention: Single trial encoding condition (1T)
Number of subjects: 21
Study 29669567 — intervention group
Group type: EXPERIMENTAL
Intervention: HERrespect intervention involving gender transformative group-based training, joint sessions, factory-wide activities, awareness raising, policy review, and community campaigns.
Number of subjects: 1195
Study 29669567 — intervention group
Group type: COMPARATOR
Intervention: Control factories (not specified in detail).
Number of subjects: 1195
Study 27325599 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrate dialysate
Number of subjects: 19
Study 27325599 — intervention group
Group type: COMPARATOR
Intervention: Acetate dialysate
Number of subjects: 19
Study 24320856 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine alone
Number of subjects: 142
Study 24320856 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin alone
Number of subjects: 142
Study 24320856 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine and pregabalin combined
Number of subjects: 142
Study 24320856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study 24320856 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 142
Study 24320856 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 142
Study 24320856 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 142
Study 21846677 — intervention group
Group type: EXPERIMENTAL
Intervention: Postconditioning (p-cond)
Number of subjects: 79
Study 21846677 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 79
Study 20979675 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai chi plus usual care
Number of subjects: 10
Study 20979675 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 10
Study 18568842 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomographic scan analysis (various methods including automated densitometric analysis and visual grading by trained radiologists)
Number of subjects: 1094
Study 18568842 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomographic scan analysis
Number of subjects: 1094
Study 15678301 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative monitoring methods (including duplex sonography, intraoperative angiograms, angioscopy, somatic evoked potentials, transcranial duplex sonography)
Number of subjects: 0
Study 15678301 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative control methods in carotid surgery
Number of subjects: 0
Study 15678301 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality control of the peripheral vascular system
Number of subjects: 0
Study 12658936 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 3 mg
Number of subjects: 70
Study 12658936 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NS
Number of subjects: 70